Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 35 to 65

Examining blood vessel health in obese adults with insulin resistance using Vitamin C

Official title: Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance

Run by University of Kansas Medical Center · NCT04715022 · Data updated 2026-11-12

This study is testing if Vitamin C can help improve blood vessel health and lower blood pressure in obese adults with insulin resistance.

More Hypertension trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages35 Years to 65 Years
SexAll
Enrollment23 (estimated)
SponsorUniversity of Kansas Medical Center
Academic / other
Locations1 site (Kansas City, Kansas)
StatusRecruiting
StartedJune 17, 2021
Main results expectedAugust 1, 2026
Study endsAugust 1, 2027
Registry record updatedJune 8, 2025
Trial IDNCT04715022 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are obese adults aged 35-65 with insulin resistance who are not currently taking certain supplements or medications.

Probably not a fit

Patients with diabetes, controlled hypertension, or a history of heart or vascular disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how obesity and insulin resistance contribute to hypertension and cardiovascular diseases by examining blood vessel health and nerve activity in affected adults. It specifically tests the effects of ascorbic acid (Vitamin C) on improving blood vessel function and lowering blood pressure. Participants will be monitored for changes in blood pressure as a primary outcome, with the goal of identifying mechanisms to reduce vascular dysfunction. The study aims to provide insights that could lead to targeted interventions for hypertension in this population.

Why it matters

Potential benefit: If successful, this study could lead to new treatments for hypertension in obese individuals with insulin resistance.

How similar studies have gone: Other studies have shown promising results in using Vitamin C for vascular health, but this specific approach in the context of obesity and insulin resistance is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Obese: BMI \>30 m/kg2
2. Middle-aged: 35-65 years
3. Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior.
4. Able and willing to provide written informed consent

Exclusion Criteria:

1. Diabetes mellitus: fasting glucose \< 1267 mg/dL and/or HbA1c \< 6.5%
2. Currently taking a statin or antihypertension medication
3. Hyperlipidemia: Fasting triglycerides \< 250 mg/dL
4. Hypertension: \<130/80 mmHg
5. History of heart disease (e.g., myocardial infarction, stent)
6. History of vascular disease (e.g., bypass, stroke)

Where it's running

  • University of Kansas Medical Center
    Kansas City, Kansas, United States
    Recruiting

Study contacts

  • Principal investigator: Seth Holwerda, PhD — University of Kansas Medical Center
  • Study coordinator: Seth Holwerda, PhD
  • Email: sholwerda@kumc.edu
  • Phone: 9729223230

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.